Literature DB >> 2314390

Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives.

J Bockaert1, M Sebben, A Dumuis.   

Abstract

Adult guinea pig hippocampal membranes contain two 5-hydroxytryptamine (5-HT) receptors positively coupled with an adenylate cyclase. One is a typical 5-HT1A receptor and the second is a nonclassical 5-HT receptor that we previously proposed to call 5-HT4. Here, we show that 4-amino-5-chlor-2-methoxy-benzamide derivatives are agonists of 5-HT4 receptors in guinea pig hippocampal membranes. Their effects on the adenylate cyclase of these membranes are not additive with those of 5-HT but are additive with those of RU 24969, a typical 5-HT1 agonist. The effects of benzamides, as well as those of 5-HT, on 5-HT4 receptors are not blocked by 5-HT1, 5-HT2, or 5-HT3 antagonists except ICS 205 903, which does so with a low affinity (1 microM). The potency of benzamides (cisapride greater than BRL 24924 greater than zacopride greater than BRL 20627 greater than metoclopramide) is similar to their effect of 5-HT4 receptors positively coupled with an adenylate cyclase of fetal mouse colliculi neurons.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314390

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  Characterization of the in vitro effects of 5-hydroxytryptamine (5-HT) on identified neurones of the rat dorsal motor nucleus of the vagus (DMV).

Authors:  K N Browning; R A Travagli
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.

Authors:  J Mialet; I Berque-Bestel; S Sicsic; M Langlois; R Fischmeister; F Lezoualc'h
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

3.  The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors.

Authors:  Karla P Zeitz; Nicolas Guy; Annika B Malmberg; Sahera Dirajlal; William J Martin; Linda Sun; Douglas W Bonhaus; Cheryl L Stucky; David Julius; Allan I Basbaum
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Blockade of the discriminative stimulus effects of ethanol with 5-HT3 receptor antagonists.

Authors:  K A Grant; J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis.

Authors:  M S Aapro
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

Review 6.  Structure and function of serotonin G protein-coupled receptors.

Authors:  John D McCorvy; Bryan L Roth
Journal:  Pharmacol Ther       Date:  2015-01-17       Impact factor: 12.310

7.  Hippocampal 5-HT Input Regulates Memory Formation and Schaffer Collateral Excitation.

Authors:  Catia M Teixeira; Zev B Rosen; Deepika Suri; Qian Sun; Marc Hersh; Derya Sargin; Iva Dincheva; Ashlea A Morgan; Stephen Spivack; Anne C Krok; Tessa Hirschfeld-Stoler; Evelyn K Lambe; Steven A Siegelbaum; Mark S Ansorge
Journal:  Neuron       Date:  2018-05-10       Impact factor: 17.173

Review 8.  Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.

Authors:  Benjamin Adam Samuels; Indira Mendez-David; Charlène Faye; Sylvain André David; Kerri A Pierz; Alain M Gardier; René Hen; Denis J David
Journal:  Neuroscientist       Date:  2014-12-08       Impact factor: 7.519

9.  A novel regulator of angiogenesis in endothelial cells: 5-hydroxytriptamine 4 receptor.

Authors:  Jasmina Profirovic; Elena Strekalova; Norifumi Urao; Aleksandar Krbanjevic; Alexandra V Andreeva; Sudhahar Varadarajan; Tohru Fukai; René Hen; Masuko Ushio-Fukai; Tatyana A Voyno-Yasenetskaya
Journal:  Angiogenesis       Date:  2012-08-18       Impact factor: 9.596

Review 10.  Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs.

Authors:  Herbert Y Meltzer; Bryan L Roth
Journal:  J Clin Invest       Date:  2013-12-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.